A randomized double-blind trial of comparative efficacy and safety of Avonex and CinnoVex for treatment of relapsing-remitting multiple sclerosis

ConclusionAvonex and CinnoVex showed similar efficacy and safety outcome in patients with RRMS.
Source: Neurological Sciences - Category: Neurology Source Type: research